EVE — Eve Health Share Price
0.000.00%
Last trade - 00:00- AU$5.27m
- AU$5.04m
- AU$2.13m
- 51
- 20
- 52
- 39
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 12.65 | ||
| Price to Tang. Book | 12.65 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.63 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -334.21% | ||
| Return on Equity | -105.17% | ||
| Operating Margin | -69.53% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 2.31 | 2.8 | 2.01 | 2.33 | 2.13 | n/a | n/a | 5.95% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
EVE Health Group Limited is an Australia-based vertically integrated producer of branded nutrition, health and wellness products. The Company’s Meluka business provides branded wellness consumer products. Its Meluka business is focused on supporting sales of its digestive health products, in particular the P3 Gut Builder. It provides probiotic supplement powder system for improved digestive health. The functional gut nutrition solution is in the form of a three-step supplement powder system, each of which contain pre, pro and postbiotics as well as selected functional superfood ingredients in an easy to consume and versatile offering. The Company also offers honey and essential oil products. Its honey products include organic raw honey and raw honey probiotic concentrate. The Company has global reach and application to various markets across Australia and New Zealand, Asia Pacific and North America.
Directors
- George Cameron-Dow NEC
- Philip Owens CEO
- Ben Rohr COO
- Gregory Fry MDR
- Steven Jackson SEC
- Jusheng Bolang DRC
- James Lin DRC
- Alasdair Cooke NED
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 1st, 2003
- Public Since
- April 8th, 2004
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 5,274,482,664
- Address
- U 1 245 Churchill Ave, SUBIACO, 6008
- Web
- https://www.evehealthgroup.com.au/
- Phone
- +61 864655500
- Auditors
- BDO Audit (WA) PTY LTD
Upcoming Events for EVE
Similar to EVE
Accent
Australian Stock Exchange - SEATS
Adairs
Australian Stock Exchange - SEATS
Autosports
Australian Stock Exchange - SEATS
Baby Bunting
Australian Stock Exchange - SEATS
Beacon Lighting
Australian Stock Exchange - SEATS
FAQ
What is the Eve Health share price?
As of Today at 20:32 UTC, shares in Eve Health are trading at AU$0.00. This share price information is delayed by 15 minutes.
How has the Eve Health share price performed this year?
Shares in Eve Health last closed at AU$0.00 and the price had moved by over the past 365 days. In terms of relative price strength the Eve Health share price has underperformed the ASX All Ordinaries Index by -3.62% over the past year.
What are the analyst and broker recommendations for Eve Health?
There is no consensus recommendation for this security.
Find out moreWhat is the Eve Health dividend yield?
Eve Health does not currently pay a dividend.
Does Eve Health pay a dividend?
Eve Health does not currently pay a dividend.
When does Eve Health next pay dividends?
Eve Health does not currently pay a dividend.
How do I buy Eve Health shares?
To buy shares in Eve Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Eve Health?
As of the previous close price of AU$0.00, shares in Eve Health had a market capitalisation of AU$5.27m.
Where are Eve Health shares listed?
Here are the trading details for Eve Health:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: EVE
What kind of share is Eve Health?
Based on an overall assessment of its quality, value and momentum Eve Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Eve Health share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Eve Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Eve Health. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +2.87%.
As of the last closing price of AU$0.00, shares in Eve Health were trading -1.96% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Eve Health PE Ratio?
The Eve Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Eve Health?
Eve Health's management team is headed by:
- George Cameron-Dow - NEC
- Philip Owens - CEO
- Ben Rohr - COO
- Gregory Fry - MDR
- Steven Jackson - SEC
- Jusheng Bolang - DRC
- James Lin - DRC
- Alasdair Cooke - NED